BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 23147756)

  • 1. Kidney transplantation and the ageing immune system.
    McKay D; Jameson J
    Nat Rev Nephrol; 2012 Dec; 8(12):700-8. PubMed ID: 23147756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplantation in the elderly patient.
    Keith DS
    Clin Geriatr Med; 2013 Aug; 29(3):707-19. PubMed ID: 23849015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppression of the elderly kidney transplant recipient.
    Danovitch GM; Gill J; Bunnapradist S
    Transplantation; 2007 Aug; 84(3):285-91. PubMed ID: 17700150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic kidney disease progression in kidney transplant recipients: A focus on traditional risk factors.
    Carminatti M; Tedesco-Silva H; Silva Fernandes NM; Sanders-Pinheiro H
    Nephrology (Carlton); 2019 Feb; 24(2):141-147. PubMed ID: 30159972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early renal graft function deterioration in recipients with preformed anti-MICA antibodies: partial contribution of complement-dependent cytotoxicity.
    Sánchez-Zapardiel E; Castro-Panete MJ; Mancebo E; Morales P; Laguna-Goya R; Morales JM; Apaza J; de Andrés A; Talayero P; Paz-Artal E
    Nephrol Dial Transplant; 2016 Jan; 31(1):150-60. PubMed ID: 26323481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of recipient age on the clinical course of renal transplantation].
    Palomar R; Ruiz JC; Cotorruelo JG; Zubimendi JA; de Francisco AL; Rodrigo E; Sanz S; Arias M
    Nefrologia; 2001; 21(4):386-91. PubMed ID: 11816515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What immunosuppression should be used for old-to-old recipients?
    Le Meur Y
    Transplant Rev (Orlando); 2015 Oct; 29(4):231-6. PubMed ID: 26409505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes in elderly kidney transplant recipients are related to acute rejection episodes rather than pretransplant comorbidity.
    Heldal K; Hartmann A; Leivestad T; Svendsen MV; Foss A; Lien B; Midtvedt K
    Transplantation; 2009 Apr; 87(7):1045-51. PubMed ID: 19352126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterizing pre-transplant and post-transplant kidney rejection risk by B cell immune repertoire sequencing.
    Pineda S; Sigdel TK; Liberto JM; Vincenti F; Sirota M; Sarwal MM
    Nat Commun; 2019 Apr; 10(1):1906. PubMed ID: 31015506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosenescence and immune response in organ transplantation.
    Martins PN; Tullius SG; Markmann JF
    Int Rev Immunol; 2014; 33(3):162-73. PubMed ID: 24127845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosenescence and organ transplantation.
    Heinbokel T; Elkhal A; Liu G; Edtinger K; Tullius SG
    Transplant Rev (Orlando); 2013 Jul; 27(3):65-75. PubMed ID: 23639337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kidney transplantation, the Halifax experience.
    Belitsky P; MacDonald AS; Lawen J; McAlister V; Bitter-Suermann H; Kiberd B; West K; Sketris I
    Clin Transpl; 1996; ():231-40. PubMed ID: 9286572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of donor and recipient age on allograft tolerance.
    Martins PN
    Exp Clin Transplant; 2009 Jun; 7(2):67-77. PubMed ID: 19715510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological characteristics of the elderly allograft recipient.
    Klinger M; Banasik M
    Transplant Rev (Orlando); 2015 Oct; 29(4):219-23. PubMed ID: 26409504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes following renal transplantation in older renal transplant recipients: a single-center experience and "Croatian senior program".
    Mikolasevic I; Racki S; Spanjol J; Zupan Z; Jakopcic I; Devcic B; Orlic L
    Int Urol Nephrol; 2015 Aug; 47(8):1415-22. PubMed ID: 26116149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppression in elderly renal transplant recipients: are current regimens too aggressive?
    Meier-Kriesche HU; Kaplan B
    Drugs Aging; 2001; 18(10):751-9. PubMed ID: 11735622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Need for individualized immunosuppression in elderly renal transplant recipients.
    Meier-Kriesche H; Ojo AO; Arndorfer JA; Leichtman AB; Lake K; Cibrik DM; Punch JD; Armstrong DR; Kaplan B
    Transplant Proc; 2001; 33(1-2):1190-1. PubMed ID: 11267252
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-Term Outcomes after Acute Rejection in Kidney Transplant Recipients: An ANZDATA Analysis.
    Clayton PA; McDonald SP; Russ GR; Chadban SJ
    J Am Soc Nephrol; 2019 Sep; 30(9):1697-1707. PubMed ID: 31308074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Characteristics of Kidney Transplant Recipients According to 1-Year Chronic Kidney Disease Stage 3a and Stage 3b Graft Function.
    Baek CH; Kim H; Yang WS; Han DJ; Park SK
    Artif Organs; 2017 Apr; 41(4):381-391. PubMed ID: 27653963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elderly Kidney Transplant Recipients: Single-Center Experience in the Middle East.
    Gheith O; Halim MA; Al-Otaibi T; El-Sayed A; Nair P; Mahmoud T; Fathy A; Hameed MA; Samy A; El Serwy N; Nagib AM
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):135-141. PubMed ID: 30777539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.